Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:17 AM
Ignite Modification Date:
2025-12-25 @ 1:17 AM
NCT ID:
NCT04727593
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of breast, prostate, or colorectal cancer;
* Cancer stage I - III;
* Primary cancer treatments completed between 3 months and 5 years (participants with ongoing adjuvant hormonal therapies will be included);
* Age between 18 and 65 years;
* Experiencing significant distress on the Distress Thermometer (DT ≥ 4)
* Willingness to accept randomization to one of the two study conditions and to attend the study for its duration;
* Ability to speak, read, and write in Portuguese and literacy to complete autonomously the self-report measures;
* Sufficient digital literacy with access to a device (e.g., smartphone; tablet; computer) with camera, microphone, and internet.
Exclusion Criteria:
* Concurrent diagnosis of severe psychiatric condition(s) (e.g., psychosis; substance abuse; bipolar disorder; suicidal ideation);
* Concurrent diagnosis of autoimmune disorder;
* Current use of antipsychotics;
* Current use of anti-inflammatory medication (corticotherapy);
* Undergoing trastuzumab therapy;
* Participation in a structured mindfulness program (e.g., MBCT; MBSR; Mindfulness-Based Cancer Recovery - MBCR) program in the past five years;
* Currently attending psychological consultation;
* Being pregnant or breastfeeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT04727593
Study Brief:
Protocol Section:
NCT04727593